Sort
82,697 grants matching “vaccine development”
Interaction of HIV envelope with cell surface receptors
$743,064Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Mechanisms of Age Dependent Powassan Virus NeurovirulenceÂ
$743,011Erich R. Mackow · State University New York Stony Brook · R01 · FY2024 · AI
Mechanisms of Age Dependent Powassan Virus NeurovirulenceÂ
$743,011Erich R. Mackow · State University New York Stony Brook · R01 · FY2025 · AI
Synthesis of Antitumor Natural Products
$742,935Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2007 · CA
International Training in AIDS-Related Epidemiology
$742,901Myron E Essex · Harvard School Of Public Health · D43 · FY2012 · TW
International Training in AIDS-Related Epidemiology
$742,901Myron E Essex · Harvard School Of Public Health · D43 · FY2009 · TW
International Training in AIDS-Related Epidemiology
$742,901Myron E Essex · Harvard School Of Public Health · D43 · FY2011 · TW
International Training in AIDS-Related Epidemiology
$742,901Myron E Essex · Harvard School Of Public Health · D43 · FY2010 · TW
Mycology Research Unit: In Vivo Induced Fungal Antigens
$742,887University Of Florida · P01 · FY2005 · AI
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2025 · CA
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2024 · CA
Structure and Function of Flaviviruses
$742,878Michael G Rossmann · Purdue University · R01 · FY2009 · AI
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak
$742,798John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2019 · AI
MOLECULAR GENETICS OF LEISHMANIA
$742,786Stephen M Beverley · Washington University · R01 · FY2011 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$742,768Joseph E Robertson · Oregon Health & Science University · P51 · FY2008 · RR
Natural Killer cells and the Immunogenetics of COVID-19
$742,765Paul John Norman · University Of Colorado Denver · R01 · FY2021 · AI
COORDINATION AND TECHNICAL SUPPORT
$742,765Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2017 · AI
Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities
$742,753Andrea Schneider Wallace · University Of Utah · R01 · FY2022 · NR
PATHOGENESIS OF MUCOSAL TRANSMISSION/ACUTE SIV INFECTION
$742,747University Of Minnesota Twin Cities · R01 · FY2001 · AI
Multimensional Robotic Flow Platform
$742,722David A. Hafler · Yale University · U19 · FY2012 · AI
Cellular Responses
$742,677David B. Weiner · Wistar Institute · U19 · FY2019 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$742,658James D. Marks · University Of California, San Francisco · U01 · FY2008 · AI
A mechanistic understanding of tuberculosis progression through bacterial reporter strains
$742,635David G Russell · Cornell University · R01 · FY2017 · AI
Natural History of Chlamydia trachomatis genital tract infection in women
$742,607Catherine M O'Connell · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
DRU: Network Structure, Behavioral Considerations and Risk Management in Interdependent Security Games
$742,534Howard C Kunreuther · University Of Pennsylvania · · FY2005 · ENG